Microbot Medical Earnings Call Transcripts
Fiscal Year 2026
-
The conference highlighted a major opportunity in the underpenetrated endovascular robotics market, with LIBERTY's fully disposable, single-use system overcoming key adoption barriers. Rapid market uptake, strong clinical validation, and a robust financial position support ongoing expansion.
-
The conference highlighted the launch and rapid adoption of a disposable, device-agnostic robotic system for endovascular procedures, addressing key unmet needs and enabling efficient workflow integration. Expansion plans include broader clinical applications, international markets, and a growing sales force.
-
Endovascular robotic-assisted surgery is a large, underpenetrated market with significant unmet needs. The LIBERTY system’s disposable, capital-free model and rapid setup have driven early adoption, with a full U.S. launch set for April 2026 and international expansion planned.